Healthcare provider profile · identity verified

Benjamin J Powers, M.D.

Internal Medicine · MERIDIAN, ID · NPI 1841204567

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	673	196
Levothyroxine Sodium	Levothyroxine Sodium	434	119
Omeprazole	Omeprazole	320	95
Amlodipine Besylate	Amlodipine Besylate	317	97
Losartan Potassium	Losartan Potassium	273	85
Gabapentin	Gabapentin	250	65
Metoprolol Succinate	Metoprolol Succinate	242	65
Lisinopril	Lisinopril	223	63
Tamsulosin Hcl	Tamsulosin Hcl	195	45
Tramadol Hcl	Tramadol Hcl	187	40
Eliquis	Apixaban	178	50
Alendronate Sodium	Alendronate Sodium	168	49
Pravastatin Sodium	Pravastatin Sodium	166	48
Jardiance	Empagliflozin	163	49
Rosuvastatin Calcium	Rosuvastatin Calcium	163	48
Metformin Hcl Er	Metformin Hcl	157	48
Metformin Hcl	Metformin Hcl	146	40
Trazodone Hcl	Trazodone Hcl	146	42
Furosemide	Furosemide	145	48
Ozempic	Semaglutide	142	25
Trulicity	Dulaglutide	128	24
Simvastatin	Simvastatin	126	35
Hydrochlorothiazide	Hydrochlorothiazide	124	38
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	112	34
Escitalopram Oxalate	Escitalopram Oxalate	108	37
Famotidine	Famotidine	100	22
Fluticasone Propionate	Fluticasone Propionate	94	36
Zolpidem Tartrate	Zolpidem Tartrate	90	18
Montelukast Sodium	Montelukast Sodium	87	25
Spironolactone	Spironolactone	87	31
Duloxetine Hcl	Duloxetine Hcl	86	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	36
Pantoprazole Sodium	Pantoprazole Sodium	82	26
Sertraline Hcl	Sertraline Hcl	82	23
Albuterol Sulfate Hfa	Albuterol Sulfate	80	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	22
Fluoxetine Hcl	Fluoxetine Hcl	79	23
Meloxicam	Meloxicam	79	38
Bupropion Xl	Bupropion Hcl	75	27
Metoprolol Tartrate	Metoprolol Tartrate	73	17
Venlafaxine Hcl Er	Venlafaxine Hcl	71	17
Pregabalin	Pregabalin	61	20
Carvedilol	Carvedilol	60	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	15
Alprazolam	Alprazolam	58	13
Celecoxib	Celecoxib	58	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	12
Allopurinol	Allopurinol	57	19
Citalopram Hbr	Citalopram Hydrobromide	51	18
Mounjaro	Tirzepatide	51	suppressed
Glipizide Er	Glipizide	49	14
Lorazepam	Lorazepam	49	18
Finasteride	Finasteride	48	11
Prednisone	Prednisone	47	16
Potassium Chloride	Potassium Chloride	43	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	13
Synthroid	Levothyroxine Sodium	40	12
Farxiga	Dapagliflozin Propanediol	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Telmisartan	Telmisartan	37	11
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Valsartan	Valsartan	34	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Cephalexin	Cephalexin	29	20
Januvia	Sitagliptin Phosphate	29	suppressed
Ondansetron Odt	Ondansetron	29	18
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	20
Clopidogrel	Clopidogrel Bisulfate	25	13
Estradiol	Estradiol	24	13
Acyclovir	Acyclovir	23	11
Buspirone Hcl	Buspirone Hcl	23	suppressed
Irbesartan	Irbesartan	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Diazepam	Diazepam	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Topiramate	Topiramate	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Primidone	Primidone	19	suppressed
Amoxicillin	Amoxicillin	18	12
Azelastine Hcl	Azelastine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Atenolol	Atenolol	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Gemtesa	Vibegron	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Indapamide	Indapamide	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error